RxSight (RXST) director granted 30,864 RSUs vesting by next meeting

Rhea-AI Filing Summary

COHEN RAYMOND W reported acquisition or exercise transactions in this Form 4 filing.

RxSight, Inc. director Raymond W. Cohen received a grant of 30,864 restricted stock units (RSUs), each representing one share of common stock. The RSUs vest 100% on the earlier of the one-year anniversary of the June 17, 2026 grant date or the next annual stockholder meeting, subject to his continued service as an Outside Director. Following this equity award, Cohen holds 66,532 shares/RSUs of RxSight common stock directly.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider COHEN RAYMOND W

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,864	$0.00	--

Holdings After Transaction: Common Stock — 66,532 shares (Direct, null)

Footnotes (1)

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Key Figures

RSUs granted: 30,864 RSUs Grant price: $0.00 per share Holdings after grant: 66,532 shares/RSUs +2 more

5 metrics

RSUs granted 30,864 RSUs Equity award to Outside Director on June 17, 2026

Grant price $0.00 per share Reported transaction price for RSU-related common stock entry

Holdings after grant 66,532 shares/RSUs Total direct ownership following the reported transaction

Vesting trigger Earlier of 1-year anniversary or next annual meeting 100% of RSUs vest on the earlier applicable date

Grant date definition June 17, 2026 Defined as the “Date of Grant” in the RSU footnote

Key Terms

restricted stock unit ("RSU"), Outside Director, 2021 Equity Incentive Plan, annual meeting of stockholders

4 terms

restricted stock unit ("RSU") financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock."

Outside Director financial

"Subject to the Reporting Person's continuing as an Outside Director ... through such applicable vesting date"

2021 Equity Incentive Plan financial

"Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date"

annual meeting of stockholders financial

"shall vest on the earlier of ... or (ii) the date of the next annual meeting of stockholders following the Date of Grant."

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

COHEN RAYMOND W

(Last) (First) (Middle)

C/O RXSIGHT, INC.

100 COLUMBIA

(Street)

ALISO VIEJO CALIFORNIA 92656

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
RxSight, Inc. [ RXST ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/17/2026		A		30,864(2)	A	(1)	66,532	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of RxSight, Inc. Common Stock.

2. Subject to the Reporting Person's continuing as an Outside Director (as defined in the Issuer's 2021 Equity Incentive Plan) through such applicable vesting date, one hundred percent (100%) of the RSUs subject to the award shall vest on the earlier of (i) the one (1) year anniversary of the Date of Grant or (ii) the date of the next annual meeting of stockholders following the Date of Grant. "Date of Grant" shall mean June 17, 2026.

Remarks:

Exhibit 24 - Power of Attorney

	/s/ Jim Schindler, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did RxSight (RXST) director Raymond W. Cohen receive in this Form 4 filing?

Raymond W. Cohen received a grant of 30,864 restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of RxSight, Inc. common stock, awarded as equity compensation for his service as an Outside Director.

When do Raymond W. Cohen’s 30,864 RxSight (RXST) RSUs vest?

All 30,864 RSUs vest 100% on the earlier of two dates. They vest on the one-year anniversary of the June 17, 2026 grant date or on the date of the next annual meeting of stockholders, assuming he continues as an Outside Director.

What is Raymond W. Cohen’s total RxSight (RXST) holding after this RSU grant?

After the award, Raymond W. Cohen holds 66,532 shares/RSUs of RxSight common stock directly. This figure includes the newly granted 30,864 RSUs and reflects his total direct ownership position reported in this Form 4 filing.

Does Raymond W. Cohen pay cash for the 30,864 RxSight (RXST) RSUs granted?

No, the RSUs are granted at a reported price of $0.00 per share. They represent a contingent right to receive shares in the future, provided vesting conditions based on continued service as an Outside Director are satisfied.

What conditions must be met for Raymond W. Cohen’s RxSight (RXST) RSUs to vest?

Vesting requires Cohen to continue serving as an Outside Director under RxSight’s 2021 Equity Incentive Plan. If he remains in that role, all RSUs vest on the earlier of the one-year grant anniversary or the next annual stockholder meeting date.